Agilon Health, Inc. carries a market capitalization of 2.04B, placing it among publicly traded companies globally. Its enterprise value stands at -66.87M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.04B |
| Enterprise Value | -66.87M |
Agilon Health, Inc. currently has 16.61M shares outstanding.
| Shares Outstanding | 16.61M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.02, and the price-to-book ratio stands at -0.07.
| PE Ratio | N/A |
| PS Ratio | 0.02 |
| PB Ratio | -0.07 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | -8.93 |
| P/OCF Ratio | -2.62 |
| EV / Sales | 0.15 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Agilon Health, Inc. maintains a current ratio of 1.04, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 18.41, indicating elevated leverage, while an interest coverage ratio of -53.70 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.04 |
| Quick Ratio | 0.89 |
| Debt / Equity | 18.41 |
| Debt / EBITDA | -0.09 |
| Interest Coverage | -53.70 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -20.63 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 18.94 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Agilon Health, Inc. has paid 1.08M in income taxes, reflecting an effective tax rate of 0.09.
| Income Tax | 1.08M |
| Effective Tax Rate | 0.09 |
Agilon Health, Inc.'s stock has gained approximately 128.2243% over the past 52 weeks. The 50-day moving average sits at 97.76, while the 200-day moving average is 38.54.
| Beta (5Y) | N/A |
| 52-Week Price Change | 128.2243% |
| 50-Day Moving Average | 97.76 |
| 200-Day Moving Average | 38.54 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Agilon Health, Inc. generated 5.82B in revenue and converted that into -354.54M in net income, yielding earnings per share of -22.51. EBITDA reached -372.54M, while operating income came in at -401.04M.
| Revenue | 5.82B |
| Gross Profit | -145.73M |
| Operating Income | -401.04M |
| Pretax Income | -372.46M |
| Net Income | -354.54M |
| EBITDA | -372.54M |
| EBIT | -401.04M |
| Earnings Per Share (EPS) | -22.51 |
Agilon Health, Inc. holds 231.41M in cash and equivalents against 33.40M in total debt, resulting in a net debt position of -109.96M. Total book value stands at -1.93B, with working capital of 48.85M providing operational flexibility.
| Cash & Cash Equivalents | 231.41M |
| Total Debt | 33.40M |
| Net Debt | -109.96M |
| Equity (Book Value) | -1.93B |
| Book Value Per Share | -116.37 |
| Working Capital | 48.85M |
Agilon Health, Inc. produced -50.05M in operating cash flow over the past twelve months. After subtracting -35.35M in capital expenditures, free cash flow totaled -85.40M - equivalent to -5.15 per share.
| Operating Cash Flow | -50.05M |
| Capital Expenditures | -35.35M |
| Free Cash Flow | -85.40M |
| FCF Per Share | -5.15 |
Agilon Health, Inc. operates with a gross margin of -2.50, reflecting its pricing power and cost economics. The operating margin of -6.89 and net profit margin of -6.09 provide insight into operational efficiency.
| Gross Margin | -2.50 |
| Operating Margin | -6.89 |
| Pretax Margin | -6.40 |
| Profit Margin | -6.09 |
| EBITDA Margin | -6.40 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 6.09 |
| FCF Yield | -11.20 |
Agilon Health, Inc.'s most recent stock split took place on March 31, 2026 with a 25:1 split ratio.
| Last Split Date | 3/31/2026 |
| Split Ratio | 25:1 |
Agilon Health, Inc. posts an Altman Z-Score of 1.34, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.34 |